Prospective analysis of 895 patients on a UK Genomics Review Board-Reference-Cited by-同舟云学术

Prospective analysis of 895 patients on a UK Genomics Review Board

Published:2019 Issue:2 Volume:4 Page:e000469
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Moore David Allan^ORCID,Kushnir Marina,Mak Gabriel,Winter Helen,Curiel Teresa,Voskoboynik Mark,Moschetta Michele,Rozumna-Martynyuk Nataliya,Balbi Kevin,Bennett Philip,Forster Martin,Kulkarni Anjana,Haynes Debra,Swanton Charles,Arkenau Hendrik-Tobias

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Cancer genomics: the challenge of drug accessibility;Lewin;Curr Opin Oncol,2015

2. Prioritizing targets for precision cancer medicine;Andre;Ann Oncol,2014

3. Cancer genomics: technology, discovery, and translation;Tran;JCO,2012

4. Delivering precision medicine in oncology today and in future—the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO);Ciardiello;Ann Oncol,2014

5. Precision oncology: an overview;Garraway;J Clin Oncol,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Tumor Boards: On the evolution of species;European Journal of Cancer;2024-04

2. Molecular tumour boards — current and future considerations for precision oncology;Nature Reviews Clinical Oncology;2023-10-16

3. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan;Cancer Science;2023-05-10

4. Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation;Critical Reviews in Oncology/Hematology;2022-08

5. Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards;Cancers;2022-06-29